Achaogen COO Promoted to Top Post, Effective Jan. 1, 2018 Post author:Sam Post published:December 11, 2017 Post category:BioPharma Dr. Hillan will remain on, and Mr. Wise will join, the Company’s Board of Directors. Source: BioSpace You Might Also Like Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ January 21, 2018 Medovex Corporation Retains CG Capital As Investor Relations Counsel April 13, 2017 Reckitt CEO's $17B Predicament December 26, 2017
